Osaic Holdings
ABBV icon

Osaic Holdings’s AbbVie ABBV Stock Holding History

Osaic Holdings’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$215M Buy
855,570
+128,649
+18% +$27.7M 0.25% 70
2026
Q1 		$158M Buy
726,921
+4,308
+0.6% +$956K 0.23% 75
2025
Q4 		$165M Sell
722,613
-11,827
-2% -$2.69M 0.24% 72
2025
Q3 		$163M Buy
734,440
+91,979
+14% +$18.7M 0.23% 79
2025
Q2 		$121M Buy
642,461
+91,364
+17% +$17M 0.22% 85
2025
Q1 		$116M Buy
551,097
+15,809
+3% +$3.07M 0.26% 71
2024
Q4 		$89.7M Sell
535,288
-10,679
-2% -$1.96M 0.2% 97
2024
Q3 		$108M Sell
545,967
-39,135
-7% -$7.3M 0.24% 78
2024
Q2 		$100M Sell
585,102
-52,513
-8% -$8.7M 0.24% 80
2024
Q1 		$116M Sell
637,615
-286,077
-31% -$49.3M 0.26% 76
2023
Q4 		$143M Sell
923,692
-284,843
-24% -$41.5M 0.25% 85
2023
Q3 		$180M Buy
1,208,535
+234,179
+24% +$34.4M 0.27% 82
2023
Q2 		$131M Sell
974,356
-57,827
-6% -$8.48M 0.24% 88
2023
Q1 		$165M Sell
1,032,183
-440
-0% -$67.3K 0.31% 65
2022
Q4 		$167M Buy
1,032,623
+50,137
+5% +$7.69M 0.34% 55
2022
Q3 		$132M Buy
982,486
+43,508
+5% +$6.24M 0.3% 64
2022
Q2 		$144M Sell
938,978
-46,507
-5% -$7.11M 0.32% 61
2022
Q1 		$151M Sell
985,485
-1,797
-0.2% -$261K 0.29% 61
2021
Q4 		$134M Buy
987,282
+412
+0% +$48.7K 0.25% 79
2021
Q3 		$107M Buy
986,870
+49,650
+5% +$5.67M 0.22% 92
2021
Q2 		$106M Buy
937,220
+37,128
+4% +$4.18M 0.23% 90
2021
Q1 		$97.5M Buy
900,092
+68,155
+8% +$7.29M 0.23% 90
2020
Q4 		$89.2M Buy
831,937
+44,911
+6% +$4.32M 0.24% 91
2020
Q3 		$69.2M Sell
787,026
-9,611
-1% -$905K 0.21% 103
2020
Q2 		$78.2M Buy
796,637
+43,699
+6% +$3.85M 0.26% 79
2020
Q1 		$57.3M Buy
+752,938
New +$64.1M 0.23% 88

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Osaic Holdings's ABBV Position: Q2 2026 in Review

Osaic Holdings increased its AbbVie (ABBV) stake by 18% in Q2 2026, buying an estimated $27.7M and bringing the position to 855,570 shares worth $215M. The position accounts for 0.25% of the portfolio, ranked #70.

Osaic Holdings first reported a position in ABBV in Q1 2020 and has held it in 26 quarters since. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Osaic Holdings held 855,570 shares of AbbVie worth $215M as of Q2 2026.
  • Osaic Holdings bought 128,649 AbbVie shares in Q2 2026, an estimated $27.7M.
  • AbbVie made up 0.25% of Osaic Holdings's portfolio in Q2 2026, its #70 holding.
  • Osaic Holdings first reported a position in AbbVie in Q1 2020 and has held it in 26 quarters since.
  • 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.